The scope of the latter provisions, in conjunction with the explanation of the explanatory note, implies that it will primarily impact on the release of GMOs for any other purpose than for placing on the market (primarily for field trials) under Part B (Articles 5 to 11) of Directive 2001/18/EC.
13 3. NATIONAL PROVISIONS NOTIFIED › 3.2. Impact on Community legislation of the national provisions notified › 3.2.1. Impact of points 5 and 6 of Article 111(2), Decision_act (EU) 2008/62
In forcesince 12 Oct 2007